U.S. Neurosurgical Inc. (USNU) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for U.S. Neurosurgical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.26M 2.56M 2.06M 1.96M 0
Cost of Goods Sold (COGS) incl. D&A 901,000 1.09M 884,000 675,000 0
COGS excluding D&A 121,000 186,000 223,000 249,000 0
Depreciation & Amortization Expense 780,000 906,000 661,000 426,000 0
Depreciation - - - 414,000 0
Amortization of Intangibles - - 0 12,000 0
Gross Income 1.36M 1.47M 1.18M 1.28M 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 918,000 1.02M 947,000 1.03M 994,000
Research & Development 0 0 0 0 0
Other SG&A 918,000 1.02M 947,000 1.03M 994,000
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 (459,000) 0 0 0
EBIT after Unusual Expense 0 459,000 0 0 0
Non Operating Income/Expense 0 0 0 954,000 0
Non-Operating Interest Income 5,000 5,000 12,000 29,000 11,000
Equity in Affiliates (Pretax) 0 (40,000) 26,000 60,000 (31,000)
Interest Expense 375,000 401,000 177,000 199,000 15,000
Gross Interest Expense 375,000 401,000 177,000 199,000 15,000
Interest Capitalized - 0 0 0 0
Pretax Income 72,000 469,000 90,000 1.09M (1.03M)
Income Tax 0 0 0 362,000 (362,000)
Income Tax - Current Domestic 0 0 0 362,000 (362,000)
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 72,000 469,000 90,000 729,000 (667,000)
Minority Interest Expense 0 0 0 0 0
Net Income 72,000 469,000 90,000 729,000 (667,000)
Extraordinaries & Discontinued Operations 0 0 (61,000) 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 (61,000) 0 0
Net Income After Extraordinaries 72,000 469,000 29,000 729,000 (667,000)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 72,000 469,000 90,000 729,000 (667,000)
EPS (Basic) 0.01 0.06 0.00 0.09 (0.09)
Basic Shares Outstanding 7.7M 7.75M 7.75M 7.8M 7.8M
EPS (Diluted) 0.01 0.06 0.00 0.09 (0.09)
Diluted Shares Outstanding 7.7M 7.75M 7.75M 7.8M 7.8M
EBITDA 1.22M 1.35M 890,000 673,000 (994,000)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for U.S. Neurosurgical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.26M 2.56M 2.06M 1.96M 0
Cost of Goods Sold (COGS) incl. D&A 901,000 1.09M 884,000 675,000 0
COGS excluding D&A 121,000 186,000 223,000 249,000 0
Depreciation & Amortization Expense 780,000 906,000 661,000 426,000 0
Depreciation - - - 414,000 0
Amortization of Intangibles - - 0 12,000 0
Gross Income 1.36M 1.47M 1.18M 1.28M 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 918,000 1.02M 947,000 1.03M 994,000
Research & Development 0 0 0 0 0
Other SG&A 918,000 1.02M 947,000 1.03M 994,000
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 (459,000) 0 0 0
EBIT after Unusual Expense 0 459,000 0 0 0
Non Operating Income/Expense 0 0 0 954,000 0
Non-Operating Interest Income 5,000 5,000 12,000 29,000 11,000
Equity in Affiliates (Pretax) 0 (40,000) 26,000 60,000 (31,000)
Interest Expense 375,000 401,000 177,000 199,000 15,000
Gross Interest Expense 375,000 401,000 177,000 199,000 15,000
Interest Capitalized - 0 0 0 0
Pretax Income 72,000 469,000 90,000 1.09M (1.03M)
Income Tax 0 0 0 362,000 (362,000)
Income Tax - Current Domestic 0 0 0 362,000 (362,000)
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 72,000 469,000 90,000 729,000 (667,000)
Minority Interest Expense 0 0 0 0 0
Net Income 72,000 469,000 90,000 729,000 (667,000)
Extraordinaries & Discontinued Operations 0 0 (61,000) 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 (61,000) 0 0
Net Income After Extraordinaries 72,000 469,000 29,000 729,000 (667,000)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 72,000 469,000 90,000 729,000 (667,000)
EPS (Basic) 0.01 0.06 0.00 0.09 (0.09)
Basic Shares Outstanding 7.7M 7.75M 7.75M 7.8M 7.8M
EPS (Diluted) 0.01 0.06 0.00 0.09 (0.09)
Diluted Shares Outstanding 7.7M 7.75M 7.75M 7.8M 7.8M
EBITDA 1.22M 1.35M 890,000 673,000 (994,000)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
